Identifying and caring for individuals with inherited cancer syndromes
Official title: Approaches to Identify and Care for Individuals With Inherited Cancer Syndromes
Run by OHSU Knight Cancer Institute · NCT04494945 · Data updated 2026-11-12
This study is testing whether free genetic testing can help find and support people with inherited cancer syndromes better than current methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 27500 (estimated) |
| Sponsor | OHSU Knight Cancer Institute Academic / other |
| Locations | 2 sites (Portland, Oregon and 1 other locations) |
| Status | Recruiting |
| Started | March 9, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT04494945 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older who may have genetic variants associated with BRCA1, BRCA2, or Lynch syndrome.
✕Probably not a fit
Patients without a family history of cancer or those who do not meet the genetic criteria for testing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial focuses on identifying and providing care for individuals with inherited cancer syndromes by offering no-cost genetic testing to the general public. The study aims to evaluate the effectiveness and sustainability of heritable cancer syndrome testing in different screening populations compared to current guidelines. Participants will provide saliva samples for genetic testing, and if positive, will receive genetic counseling. Additionally, participants will complete a survey regarding cancer prevention, screening, and treatment.
Why it matters
Potential benefit: If successful, this study could enhance early detection and management of hereditary cancer syndromes, potentially improving patient outcomes.
How similar studies have gone: Other studies have shown success with similar genetic testing approaches, indicating potential for effective implementation in broader populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ALL COHORTS: 18 years of age or older * Retrospective COHORT A: Per HIPAA waiver, Retrospective Cohort A will not actively consent * Retrospective COHORT A: Patients may or may not be diagnosed with cancer * Retrospective COHORT A: Patients have received genetic counseling in the past 5 years * Retrospective COHORT A: Patients have genetic variants that include BRCA1, BRCA2 and/or Lynch syndrome * COHORT A: Per Health Insurance Portability and Accountability Act (HIPAA) waiver, Cohort A returns survey as consent * COHORT A: Patients may or may not be diagnosed with cancer * COHORT A: Patients have received genetic counseling in the past 1 - 2 years * COHORT A: Patients have genetic variants that include BRCA1, BRCA2 and/or Lynch syndrome * COHORT A: INCLUSIVE of no contact list to exclude from Cohort B * COHORT B: Creation of secure Healthy Oregon Project (HOP) app account * COHORT B: Consent to this project, either hard or electronic signature * COHORT B: Consent to the HOP repository, either hard or electronic signature * COHORT B: Choosing to submit a deoxyribonucleic acid (DNA) sample * COHORT B: Patients diagnosed with any National Cancer Institute (NCI)-reportable cancers, including ductal carcinoma in situ (DCIS) and/or in situ breast cancer * COHORT B: Must have had an encounter within past twelve months * COHORT B: Exclude Cohort A * COHORT C: Creation of secure Hop app account * COHORT C: Consent to this project, either hard or electronic signature * COHORT C: Consent to the HOP repository, either hard or electronic signature * COHORT C: Choosing to submit a DNA sample
Where it's running
-
Providence Portland Medical Center
Portland, Oregon, United States Recruiting -
OHSU Knight Cancer Institute
Portland, Oregon, United States Recruiting
Study contacts
- Principal investigator: Jackilen Shannon, Ph.D. — OHSU Knight Cancer Institute
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce psychological symptom burden during cancer treatment
This trial will try virtual reality sessions to reduce anxiety, depression, and adjustment symptoms for adults receiving cancer treatment.
-
Connecting underrepresented populations to clinical trials at Ohio State University
This study is trying to find better ways to connect racial and ethnic minorities to cancer clinical trials at Ohio State University to help them participate more.
-
Virtual group therapy to improve psychological wellbeing in cancer patients
This study is testing if virtual group therapy that combines acceptance and commitment therapy with compassion can help improve the mental wellbeing of cancer patients.
-
Community-based exercise program for cancer survivors
This study tests a 12-week exercise program for cancer survivors to see if it helps them feel better and improves their quality of life.
-
New blood and urine tests for cancer screening
This study is testing new blood and urine tests for cancer screening to see how well they work in people without known cancer and how different health factors might affect the results.
-
Telemedicine support for older cancer patients in underserved communities
This study tests whether using telemedicine to provide extra support can help older cancer patients in underserved communities feel better and have fewer hospital visits compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.